Retracted: Efficacy, Safety, and Impact on Patient Survival of PDL1/PD-1 Inhibitors versus FOLFIRINOX Regimens for Advanced Pancreatic Cancer

Detalles Bibliográficos
Autor principal: Methods in Medicine, Computational and Mathematical
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322466/
https://www.ncbi.nlm.nih.gov/pubmed/37416243
http://dx.doi.org/10.1155/2023/9849436
_version_ 1785068761912442880
author Methods in Medicine, Computational and Mathematical
author_facet Methods in Medicine, Computational and Mathematical
author_sort Methods in Medicine, Computational and Mathematical
collection PubMed
description
format Online
Article
Text
id pubmed-10322466
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-103224662023-07-06 Retracted: Efficacy, Safety, and Impact on Patient Survival of PDL1/PD-1 Inhibitors versus FOLFIRINOX Regimens for Advanced Pancreatic Cancer Methods in Medicine, Computational and Mathematical Comput Math Methods Med Retraction Hindawi 2023-06-28 /pmc/articles/PMC10322466/ /pubmed/37416243 http://dx.doi.org/10.1155/2023/9849436 Text en Copyright © 2023 Computational and Mathematical Methods in Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Methods in Medicine, Computational and Mathematical
Retracted: Efficacy, Safety, and Impact on Patient Survival of PDL1/PD-1 Inhibitors versus FOLFIRINOX Regimens for Advanced Pancreatic Cancer
title Retracted: Efficacy, Safety, and Impact on Patient Survival of PDL1/PD-1 Inhibitors versus FOLFIRINOX Regimens for Advanced Pancreatic Cancer
title_full Retracted: Efficacy, Safety, and Impact on Patient Survival of PDL1/PD-1 Inhibitors versus FOLFIRINOX Regimens for Advanced Pancreatic Cancer
title_fullStr Retracted: Efficacy, Safety, and Impact on Patient Survival of PDL1/PD-1 Inhibitors versus FOLFIRINOX Regimens for Advanced Pancreatic Cancer
title_full_unstemmed Retracted: Efficacy, Safety, and Impact on Patient Survival of PDL1/PD-1 Inhibitors versus FOLFIRINOX Regimens for Advanced Pancreatic Cancer
title_short Retracted: Efficacy, Safety, and Impact on Patient Survival of PDL1/PD-1 Inhibitors versus FOLFIRINOX Regimens for Advanced Pancreatic Cancer
title_sort retracted: efficacy, safety, and impact on patient survival of pdl1/pd-1 inhibitors versus folfirinox regimens for advanced pancreatic cancer
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322466/
https://www.ncbi.nlm.nih.gov/pubmed/37416243
http://dx.doi.org/10.1155/2023/9849436
work_keys_str_mv AT methodsinmedicinecomputationalandmathematical retractedefficacysafetyandimpactonpatientsurvivalofpdl1pd1inhibitorsversusfolfirinoxregimensforadvancedpancreaticcancer

Ejemplares similares